Ads
related to: eli lilly
Search results
Eli Lilly adds ALS drug prospect with QurAlis deal
BioPharma Dive via Yahoo Finance· 2 days agoThe alliance hands Lilly an RNA-based therapy in preclinical testing for ALS and frontotemporal dementia, and includes a research collaboration to...
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
The Motley Fool via AOL· 2 days agoEli Lilly and Novo Nordisk are, so far, the kings of the weight-loss gold rush. Thanks to their medicines, Zepbound and Wegovy, billions in new revenue ...
Lilly seeks to build conference center on downtown HQ campus - Indianapolis Business Journal
Indianapolis Business Journal· 5 days agoEli Lilly and Co. plans to build a 57,000-square-foot conference center on an existing parking lot...
Ozempic and weight loss drug shortages can now be tracked by patients
Quartz· 6 days agoAs Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 2 days agoBuying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a...
The Zacks Analyst Blog Highlights Eli Lilly, T-Mobile US, BHP, American International and Exelon
Zacks· 2 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 4 days agoEli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all...
Lilly gilds neuro pipeline, paying QurAlis $45M for preclinical ALS, dementia prospect
FierceBiotech· 2 days agoEli Lilly is splicing another asset onto its neurodegenerative disease pipeline, paying QurAlis $45 million for rights to a preclinical treatment for amyotrophic ...
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030
Motley Fool via Yahoo Finance· 3 days agoHowever, some companies in the field look so promising that they could deliver well-above-average...
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030 | The Motley Fool
The Motley Fool· 3 days agoThere are several candidates here, but two of the most attractive today are Eli Lilly (LLY 0.65%)...